March 2024

Contents

Editorial

• UK guide to PrEP now online: major update (2024)

Conference reports

• CROI 2024: Opening lecture calls for scientists to speak up for LGBTQ+ rights in Uganda

• CROI 2024: Pipeline ART – new drugs and formulations

• CROI 2024: Studies using tecovirimat to treat mpox

• CROI 2024: Promising results from first study of long-acting treatment in Africa

• CROI 2024: HIV studies with semaglutide: significant benefits but limited access for treatment and research

• CROI 2024: studies to watch for at this upcoming conference

Antiretrovirals

• Roche to discontinue enfuvirtide (T-20, Fuzeon)

Guidelines

• US guidelines recommend earlier use of statins in people living with HIV